FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound that inhibits Pin1 (peptidyl-prolyl-cis/trans isomerase interacting with NIMA 1), or a pharmaceutically acceptable salt thereof, a method of producing the said compound, a pharmaceutical composition containing as an active ingredient a compound that inhibits Pin1, and its use for the prevention or treatment of malignancy.
EFFECT: obtaining a new compound and a method of its preparation.
18 cl, 5 tbl, 185 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587981C2 |
| NOVEL DERIVATIVE OF PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYLSULPHONAMIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH HAS INHIBITION ACTIVITY WITH RESPECT TO RAF-KINASE, CONTAINING CLAIMED COMPOUND AS ACTIVE INGREDIENT | 2011 |
|
RU2550038C2 |
| COMPOUND INHIBITING FORMATION OF C-MYC/MAX/DNA COMPLEX | 2017 |
|
RU2727177C1 |
| AMINOPYRIMIDINE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2826628C1 |
| NEW PYRIMIDINE DERIVATIVE WITH AN EFFECT OF INHIBITING GROWTH OF CANCER CELLS AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2018 |
|
RU2744168C1 |
| DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587493C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| ANTICANCER PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2724340C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| COMPOUND CONTAINING OXADIAZOLE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2789456C2 |
